Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Nov 10, 2016, during market hours
10-Q filed Nov 14, 2016, 45 days after period end · 0001144204-16-134339
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $184.00K | $285.00K | $236.00K | $189.00K |
| Net Income | -$2.62M | -$6.07M | -$1.47M | -$157.00K |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.19 |
| -$4.15 |
| -$1.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.